Antibody-Based Therapeutics
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
112
NCT04633772
Use of Angiotensin-(1-7) in COVID-19
Phase: Phase 1/2
Role: Collaborator
Start: Aug 5, 2020
Completion: Nov 1, 2021
Loading map...